50. 皮膚筋炎／多発性筋炎 Dermatomyositis Clinical trials / Disease details

臨床試験数 : 194 / 薬物数 : 244 - (DrugBank : 89) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 151

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-001200-15-IT (EUCTR)	16/08/2021	18/10/2021	Ravulizumab versus Placebo in Adult Participants with Dermatomyositis.	A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Eval ...	Dermatomyositis;Therapeutic area: Diseases [C] - Immune System Diseases [C20]	Trade Name: Ultomiris Product Name: Ravulizumab Product Code: [ALXN1210] INN or Proposed INN: RAVULIZUM ...	ALEXION PHARMACEUTICALS INCORPORATED	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 2;Phase 3	France;United States;Spain;Germany;United Kingdom;Japan;Italy;Korea, Republic of

First Previous1Next Last